What a joke of a company that must feel an impending blow to its crap product after all the good news coming from its PEMF competitor (Bioelectronics). This article implies that there was a unbiased trial performed between the two products. When in fact they are only citing statistics (accurate?) between the two products. There was never a controlled study performed comparing results.

And how about this ridiculous source of referral for the verification of the content of this article. LOL!!! :

"For full references regarding claims in this news release, contact Endonovo’s Investor Relations."

LOL, I was waiting for this (reference) to be a legitimate unbiased source but NO, verification form the most biased of sources. WOW!!!!